Ritch N. Wood
Chief Executive Officer
Ritch Wood was appointed Nu Skin’s chief executive officer in 2017. Previously, Wood served in various capacities at Nu Skin including chief financial officer, vice president of finance, vice president of new market development, director of finance of new market development and controller of the Pharmanex division. He also played a key role in opening many European countries for Nu Skin during an expatriate assignment from1995 to 1997. Prior to his assignment in Europe, he served as the assistant director of international tax.
Wood worked for the international accounting firm of Grant Thornton prior to joining Nu Skin in 1993. He earned a Bachelor of Science and Master of Accountancy, taxation emphasis, from Brigham Young University and in 2010 was named a CFO of the Year by Utah Business magazine.
Ryan Napierski currently serves as Nu Skin's president. Prior to his current appointment, he served as president of global sales and operations, president of Nu Skin’s North Asia region and president of Nu Skin Japan.
Napierski has also served as vice president of business development and chief operating officer for the North Asia region. He has fulfilled multiple positions for Nu Skin since joining the company in 1995, including vice president of global business development, general manager for the United Kingdom, vice president of European business development and key account manager for United States executives.
Napierski earned a Bachelor of Science, a Master of Business Administration from Duke University and a Master of International Business from Goethe Universitat in Germany.
Joseph Y. Chang, Ph.D.
Chief Scientific Officer and Executive Vice President, Product Development
Joseph Y. Chang, Ph.D., was appointed chief scientific officer and executive vice president of product development in 2006. A prolific author, Dr. Chang has published numerous articles, reviews and books on pharmacological research, including the New York Times best seller, The Aging Myth. With 35 years of experience in the pharmaceutical and dietary supplement industries, Dr. Chang enjoys a comprehensive knowledge of both of these industries and serves as a member of the Executive Committee for Nu Skin Enterprises. Prior to the acquisition of Pharmanex by Nu Skin Enterprises in 1998, he served as the vice president of clinical studies and pharmacology at Pharmanex.
Prior to Pharmanex, Dr. Chang served as president and chief scientific officer of Osteoarthritis Sciences, Inc., from 1991 to 1994 and Binary Therapeutics, Inc. from 1994 to 1997. He has also held various research management positions at Wyeth-Ayerst, Rhone Poulenc Rorer and other biotechnology companies, where he was involved in researching natural products for arthritis and immunosuppressive treatment. He received a Bachelor of Science from Portsmouth University and a Doctorate from the University of London.
D. Matthew Dorny
Vice President, General Counsel and Secretary
D. Matthew Dorny was appointed vice president and general counsel for Nu Skin in 2003. From 1998 to 2003, Dorny served as the assistant general counsel for Nu Skin Enterprises. Prior to joining Nu Skin Enterprises, Dorny was a securities and business attorney in private practice. Dorny received a Bachelor of Arts, Master of Business Management and Juris Doctorate degrees from the University of Utah.
Chief Financial Officer
Mark Lawrence was appointed Nu Skin’s chief financial officer in March 2017. Lawrence brings 20 years of operational and financial experience to the role. He recently served as the head of finance for Amazon-Lab126, where he was responsible for the company’s global finance functions and played a key role in the launch of several Amazon devices. In addition, he has held senior financial leadership roles at Silicon Valley-based companies Polycom and Brocade as well as Utah-based Vivint Smart Home.
Lawrence received a Bachelor of Science from Brigham Young University and a Master of Business Administration from the University of California, Davis.